EQS-News: Alzchem Group AG
/ Key word(s): Share Buyback
Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, December 23rd, 2024
3rd Interim Report
In the period from December 16th up to and including December 20th, 2024, a total of 9,277 shares of Alzchem Group AG were acquired as part of the share buyback programme announced on November 29th, 2024. The total number of shares acquired to date as part of this buyback amounts to 25,578. The acquisition was carried out by a financial institution via the stock exchange (XETRA) on behalf of Alzchem Group AG.
The total number of repurchased shares, the weighted average price and the aggregated volume (excl. acquisition costs) per day were as follows:
This information as well as the detailed information on the individual daily transactions related to the buy-back programme are also published on the Company's website at https://www.alzchem.com/en/investor-relations/stock/#c18518 in accordance with Art. 2 par. 3 sentence 2 of Delegated Regulation (EU) 2016/1052.
Alzchem Group AG - Managing Board -
23.12.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
Language: | English |
Company: | Alzchem Group AG |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Germany | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
EQS News ID: | 2056953 |
End of News | EQS News Service |
|
2056953 23.12.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.